Jakura 5mg tablet contains Tofacitinib 5 mg, a JAK inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). It helps reduce joint pain, swelling, stiffness, and slows the progression of joint damage by controlling inflammation. Common medications for rheumatoid arthritis include Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Tofacitinib, Baricitinib, Adalimumab, and Etanercept. Jakura is generally prescribed when patients do not respond adequately to conventional DMARDs. The dosage should be taken strictly under medical supervision, usually 5 mg twice daily, as advised by a rheumatologist. Regular monitoring is recommended during treatment.